FORMATION OF STABLE P53 HOMOTETRAMERS AND MULTIPLES OF TETRAMERS

被引:116
作者
STENGER, JE [1 ]
MAYR, GA [1 ]
MANN, K [1 ]
TEGTMEYER, P [1 ]
机构
[1] SUNY STONY BROOK,DEPT MICROBIOL,STONY BROOK,NY 11794
关键词
OLIGOMERIZATION; QUATERNARY STRUCTURE; TUMOR SUPPRESSOR;
D O I
10.1002/mc.2940050204
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used gradient gel electrophoresis and chemical cross-linking to analyze the quaternary structure of purified, wild-type, murine p53. Under nondenaturing conditions, p53 electrophoreses as tetramers and multiples of tetramers. Under denaturing conditions, fully cross-linked p53 also behaves as tetrameric structures. We confirmed the composition of the tetramers by partially cross-linking p53 and dissociating tetramers into monomers, dimers, and trimers.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 34 条
[1]  
BARGONETTI J, 1991, CELL, V65, P1
[2]   PURIFICATION OF COMPLEXES OF NUCLEAR ONCOGENE-P53 WITH RAT AND ESCHERICHIA-COLI HEAT-SHOCK PROTEINS - INVITRO DISSOCIATION OF HSC70 AND DNAK FROM MURINE-P53 BY ATP [J].
CLARKE, CF ;
CHENG, K ;
FREY, AB ;
STEIN, R ;
HINDS, PW ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (03) :1206-1215
[4]   PRESENCE OF A POTENT TRANSCRIPTION ACTIVATING SEQUENCE IN THE P53 PROTEIN [J].
FIELDS, S ;
JANG, SK .
SCIENCE, 1990, 249 (4972) :1046-1049
[5]   ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE [J].
FINLAY, CA ;
HINDS, PW ;
TAN, TH ;
ELIYAHU, D ;
OREN, M ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) :531-539
[6]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[7]   FUNCTIONAL INACTIVATION OF GENES BY DOMINANT NEGATIVE MUTATIONS [J].
HERSKOWITZ, I .
NATURE, 1987, 329 (6136) :219-222
[8]  
JAENICKE R, 1990, FEBS LETT, V260, P233, DOI 10.1016/0014-5793(90)80111-U
[9]   ISOLATION OF CDNA-ENCODING TRANSCRIPTION FACTOR SP1 AND FUNCTIONAL-ANALYSIS OF THE DNA-BINDING DOMAIN [J].
KADONAGA, JT ;
CARNER, KR ;
MASIARZ, FR ;
TIJIAN, R .
CELL, 1987, 51 (06) :1079-1090
[10]  
KERN SE, 1991, ONCOGENE, V6, P131